Online Inquiry
Cat.#: ACPP-1368
| Despition | KCNJ2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1813 | Human HAAO Protein (AC1813) | 5 µg | inquiry |
| ACPP-1248 | Mitofusin 2 Blocking Peptide (AC1248) | 250 µg | inquiry |
| ACPP-1149 | Recombinant Human TNF Receptor II Protein (Fc Tag) (AC1149) | 50 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
| ACPP-1427 | Human ASMT Protein (AC1427) | 5 µg | inquiry |
| ACPP-1311 | Human LIF Protein (AC1311) | 3 x 2 µg | inquiry |
| ACPP-1286 | Bestrophin 2 Blocking Peptide (AC1286) | 250 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg | inquiry |
| ACPP-1621 | Human LZIC Protein (AC1621) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.